GlassScriptPhysician profile
Jason A Brown
NPI 1386807428
$17,994.54
in general payments reported to CMS, 2019-2025
18 companies · $2,205 in 2025
The $2,205 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,738 · 2020: $1,117 · 2021: $3,723 · 2022: $2,680 · 2023: $3,102 · 2024: $1,430 · 2025: $2,205.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $4,712 · Food and Beverage: $2,024.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $4,712.44 |
| Food and Beverage | $2,024.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $8,377.94 | 2019-2025 | Arthrex |
| Rock Medical Orthopedics, INC. | $6,502.32 | 2020-2023 | |
| Cdc Medical LLC | $1,551.36 | 2019 | |
| Nexus Medical Technologies LLC | $650.07 | 2025 | |
| Stryker Corporation | $316.58 | 2019-2024 | Blueprint Patient Specific Instrumentation, Aequalis Ascend Flex |
| Vericel Corporation | $172.82 | 2024-2025 | Maci |
| Heron Therapeutics, INC. | $140.10 | 2022-2023 | Zynrelef |
| Tg Therapeutics, INC. | $68.73 | 2023-2025 | |
| Zimmer Biomet Holdings, INC. | $46.79 | 2024 | Gel-One Cross-Linked Hyaluronate |
| Pacira Pharmaceuticals Incorporated | $31.32 | 2024 | Exparel, Iovera, Zilretta |
| Wright Medical Technology, INC. | $28.99 | 2019-2020 | |
| Horizon Therapeutics Plc | $25.45 | 2019-2020 | |
| Pacira Therapeutics, INC. | $23.04 | 2019 | |
| Ucb, INC. | $18.11 | 2025 | Zilbrysq |
| Vertex Pharmaceuticals Incorporated | $17.00 | 2025 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medline Industries LP | $12.04 | 2021 | |
| Hydrocision, INC. | $11.88 | 2022 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Brown listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.